Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.41 |
| ▸ | TUBB | P07437 | 1/20 | 0.41 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.41 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.41 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.41 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.41 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.41 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.41 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.41 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.41 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.41 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3952349 | 0.87 | TRPA1 (0.45) | CYP1A2CYP2A6TRPA1AKR1C3AKR1C2 | |
| SCHEMBL10337363 | 0.85 | HPGD (0.42) | CYP1A2 | |
| SCHEMBL11470643 | 0.83 | LCK (0.43) | AKR1C3AKR1C2TUBB4ATUBBTUBA3C | |
| SCHEMBL6351021 | 0.83 | TRPA1 (0.55) | CYP1A2CYP2A6TRPA1AKR1C3AKR1C2 | |
| SCHEMBL8362494 | 0.80 | LDHA (0.53) | CYP1A2CYP2A6AKR1C3AKR1C2 | |
| SCHEMBL8653130 | 0.79 | CYP1A2 (0.48) | CYP1A2CYP2A6TRPA1AKR1C3AKR1C2 | |
| SCHEMBL4123235 | 0.78 | CYP1A2 (0.47) | CYP1A2CYP2A6TRPA1AKR1C3AKR1C2 | |
| SCHEMBL7599568 | 0.77 | AKR1C3 (0.46) | CYP1A2CYP2A6TRPA1AKR1C3AKR1C2 | |
| SCHEMBL8974260 | 0.77 | MEN1 (0.45) | CYP1A2CYP2A6TUBB4ATUBBTUBA3C | |
| SCHEMBL7843943 | 0.76 | CYP1A2 (0.54) | CYP1A2CYP2A6TRPA1AKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7514520-B2 | Process for producing phosphonitrilic acid ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-04-07 | — | — | US | disclosed |
| US-20080091050-A1 | Process For Producing Phosphonitrilic Acid Ester | ASAHI KASEI CHEMICAL CORPORATION (JP) | 2008-04-17 | — | — | US | disclosed |
| US-20070060739-A1 | Process for producing phosphonitrilic acid ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2007-03-15 | — | — | US | disclosed |
| CN-1798753-A | Process for producing phosphonitrilic acid ester | ASAHI CHEMICAL CORP (JP) | 2006-07-05 | — | — | CN | disclosed |
| EP-0669328-B1 | Complexes of morpholine derivatives and ketocarboxylic acids as corrosion inhibitors | CIBA GEIGY AG (CH) | 1998-09-30 | — | — | EP | disclosed |
| EP-0619290-B1 | Salts of alkaline earth metals and transition metals as well as complexes of transition metals of ketocarboxylic acids and their use as corrosion inhibitors | CIBA GEIGY AG (CH) | 1996-10-09 | — | — | EP | disclosed |
| US-5519074-A | PROTECTIVE | CIBA-GEIGY CORPORATION (US) | 1996-05-21 | — | — | US | disclosed |
| US-5458678-A | Alkaline earth metal salts, transition metal salts and transition metal complexes of ketocarboxylic acids as corrosion inhibitors | CIBA-GEIGY CORPORATION (US) | 1995-10-17 | — | — | US | disclosed |
| EP-0669328-A1 | Complexes of morpholine derivatives and ketocarboxylic acids as corrosion inhibitors | CIBA-GEIGY AG (CH) | 1995-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080091050-A1 | Process For Producing Phosphonitrilic Acid Ester | PHOSPHO1, GNPAT, SELENOI | CYP1A2 1255/4885CYP2A6 929/4885TRPA1 3002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.